Yelena Kotlarsky, Aaron Lipson and Nikki Reeves examine the insider trading risks posed by prediction markets tied to clinical drug trial outcomes in Law360. The article discusses how participants with access to material nonpublic information about trial results may create regulatory and enforcement challenges as these markets continue to evolve.

Read More